Chemotherapy-Induced Pulmonary Toxicity in Lung Cancer Patients
Receiver Operating Characteristic Curve in Diagnostic Test Assessment
Molecular Predictors of Sensitivity to the MET Inhibitor PHA665752 in Lung Carcinoma Cells
Deregulation of p27 and Cyclin D1/D3 Control Over Mitosis Is Associated with Unfavorable Prognosis in Non-small Cell Lung Cancer, as Determined in 405 Operated Patients
ERCC2/XPD Lys751Gln and Asp312Asn Gene Polymorphism and Lung Cancer Risk
Correlation Between Polymorphisms of the Reduced Folate Carrier Gene (SLC19A1) and Survival After Pemetrexed-Based Therapy in Non-small Cell Lung Cancer
Prognostic Stratification of Stage IIIA pN2 Non-small Cell Lung Cancer by Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data
Histopathologic Features of the Tumor Budding in Adenocarcinoma of the Lung
Japanese Lung Cancer Registry Study
Adjuvant Chemotherapy Based on the In Vitro Histoculture Drug Response Assay for Non-small Cell Lung Cancer Improves Survival
Chemoradiotherapy and Gefitinib in Stage III Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor and KRAS Mutation Analysis
Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy for Patients with Locally Advanced Non-small Cell Lung Cancer
Modest Reductions in Dose Intensity and Drug-Induced Neutropenia have No Major Impact on Survival of Patients with Non-small Cell Lung Cancer Treated with Platinum-Doublet Chemotherapy
Pharmacokinetics of Gefitinib Predicts Antitumor Activity for Advanced Non-small Cell Lung Cancer
Anti-Vascular Endothelial Growth Factor Treatment in Combination with Chemotherapy Delays Hematopoietic Recovery Due to Decreased Proliferation of Bone Marrow Hematopoietic Progenitor Cells
Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell Lung Cancer
Chemotherapy Response in East Asian Non-small Cell Lung Cancer Patients Harboring Wild-Type or Activating Mutation of Epidermal Growth Factor Receptors
A Randomized Phase II Study of a Combination of Docetaxel and S-1 versus Docetaxel Monotherapy in Patients with Non-small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy
Severe Interstitial Lung Disease Associated with Amrubicin Treatment
Insulin-Like Growth Factor-1 Receptor Expression in Thymic Malignancies
Expression and Mutational Status of c-kit in Thymic Epithelial Tumors
The Role of Radiation Therapy in Malignant Thymoma
Sensitivity of Urinary Mesothelin in Patients with Malignant Mesothelioma
Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma
Cetuximab as Second-Line Therapy in Patients with Metastatic Esophageal Adenocarcinoma
Side-Effects of Long-Term Administration of Erlotinib in Patients with Non-small Cell Lung Cancer
Lung Cancer with Unusual Presentation as a Thin-Walled Cyst in a Young Nonsmoker
Cardiac Sarcomas
Atypical Thymoma (World Health Organization Type B3) with Neuroendocrine Differentiation Combined with Hyperparathyroidism
Pulmonary Pleomorphic Carcinoma
Pulmonary Pleomorphic Carcinoma